Our Reports
Automotive Reports Electronics & Semiconductor Telecom & IT Technology & IT Consumer Goods Healthcare Food & Beverages Chemical
Our Links
About Us Contact Us Press Release News Our Blogs

Int'l : +1(646) 600-5072 | query@kbvresearch.com

Asia Pacific Carrier Screening Market By Technology (DNA Sequencing, Microarrays, Polymerase Chain Reaction and Other technology), By End user (Hospital and Clinics, Physician Offices, Reference Laboratories and Other End Users), By Country, Opportunity Analysis and Industry Forecast, 2021 - 2027

Published Date : 22-Dec-2021

Pages: 82

Formats: PDF

The Asia Pacific Carrier Screening Market would witness market growth of 12.58% CAGR during the forecast period (2021-2027).

The chances to cure and effectively manage a disease would grow manifold if it is diagnosed early. Treatment of the disease early may help the patient to accommodate it in a better way. Early disease detection assists individuals plan ahead, while they are still able to take valuable decisions in terms of their health and bolsters requirements and on financial and legal matters. Genetic disorders like sickle cell anemia, cystic fibrosis, and Tay-Sachs disease, are inherited disorders that are deadly in nature. However, carrier screening for these fatal diseases can offer valuable data regarding a couple’s possibility of having a child with a genetic disorder.

There is a growing demand for different diagnosis methods like carrier screening in developing countries like India, Japan, and China. This surging demand for wearables would bolster the growth of the regional carrier screening market in the upcoming years. In addition, the rising cases of people suffering from different diseases will also positively impact the growth of the market in this region.

The Asia Pacific is witnessing high consumer awareness regarding their health and a surge in the number of chronic diseases. This would act as a major catalyst for the growth of the regional carrier screening market. Moreover, players operating in this region are constantly developing different kinds of products to explore the genetic errors in the human body that would help the people to prevent the chances of transmission of the defected genes to their offspring. These factors are expected to open new growth avenues for the players operating in the regional carrier screening market during the forecasting period.

The China market dominated the Asia Pacific Carrier Screening Market by Country in 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $158.2 million by 2027. The Japan market is poised to grow a CAGR of 13.9% during (2021 - 2027). Additionally, The India market is anticipated to grow a CAGR of 14% during (2021 - 2027).

Based on Technology, the market is segmented into DNA Sequencing, Microarrays, Polymerase Chain Reaction and Other technology. Based on End user, the market is segmented into Hospital and Clinics, Physician Offices, Reference Laboratories and Other End Users. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

Free Valuable Insights: The Worldwide Carrier Screening Market is Projected to reach USD 2,501.94 Million by 2027, at a CAGR of 10.81%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Quest Diagnostics, Incorporated, Thermo Fisher Scientific, Illumina, Inc., Eurofins Scientific Group, Invitae Corporation, OPKO Health, Inc., Fulgent Genetics, Sema4 OpCo, Inc., Myriad Genetics, Inc., and Natera, Inc.

Scope of the Study

Market Segments Covered in the Report:

By Type

  • Expanded Carrier Screening and
  • Targeted Disease Carrier Screening

By Technology

  • DNA Sequencing
  • Microarrays
  • Polymerase Chain Reaction and
  • Other technology

By End User

  • Hospital and Clinics
  • Physician Offices
  • Reference Laboratories and
  • Other End Users

By Country

  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific

Key Market Players

List of Companies Profiled in the Report:

  • Quest Diagnostics, Incorporated
  • Thermo Fisher Scientific
  • Illumina, Inc.
  • Eurofins Scientific Group
  • Invitae Corporation
  • OPKO Health, Inc.
  • Fulgent Genetics
  • Sema4 OpCo, Inc.
  • Myriad Genetics, Inc.
  • Natera, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Carrier Screening Market, by Type
1.4.2 Asia Pacific Carrier Screening Market, by Technology
1.4.3 Asia Pacific Carrier Screening Market, by End User
1.4.4 Asia Pacific Carrier Screening Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions: 2017, Jun – 2021, Jun) Leading Players

Chapter 4. Asia Pacific Carrier Screening Market by Type
4.1 Asia Pacific Expanded Carrier Screening Market by Country
4.2 Asia Pacific Targeted Disease Carrier Screening Market by Country

Chapter 5. Asia Pacific Carrier Screening Market by Technology
5.1 Asia Pacific DNA Sequencing Market by Country
5.2 Asia Pacific Microarrays Market by Country
5.3 Asia Pacific Polymerase Chain Reaction Market by Country
5.4 Asia Pacific Other Technologies Market by Country

Chapter 6. Asia Pacific Carrier Screening Market by End user
6.1 Asia Pacific Hospital and Clinics Market by Country
6.2 Asia Pacific Physician Offices Market by Country
6.3 Asia Pacific Reference Laboratories Market by Country
6.4 Asia Pacific Other End user Market by Country

Chapter 7. Asia Pacific Carrier Screening Market by Country
7.1 China Carrier Screening Market
7.1.1 China Carrier Screening Market by Type
7.1.2 China Carrier Screening Market by Technology
7.1.3 China Carrier Screening Market by End user
7.2 Japan Carrier Screening Market
7.2.1 Japan Carrier Screening Market by Type
7.2.2 Japan Carrier Screening Market by Technology
7.2.3 Japan Carrier Screening Market by End user
7.3 India Carrier Screening Market
7.3.1 India Carrier Screening Market by Type
7.3.2 India Carrier Screening Market by Technology
7.3.3 India Carrier Screening Market by End user
7.4 South Korea Carrier Screening Market
7.4.1 South Korea Carrier Screening Market by Type
7.4.2 South Korea Carrier Screening Market by Technology
7.4.3 South Korea Carrier Screening Market by End user
7.5 Singapore Carrier Screening Market
7.5.1 Singapore Carrier Screening Market by Type
7.5.2 Singapore Carrier Screening Market by Technology
7.5.3 Singapore Carrier Screening Market by End user
7.6 Malaysia Carrier Screening Market
7.6.1 Malaysia Carrier Screening Market by Type
7.6.2 Malaysia Carrier Screening Market by Technology
7.6.3 Malaysia Carrier Screening Market by End user
7.7 Rest of Asia Pacific Carrier Screening Market
7.7.1 Rest of Asia Pacific Carrier Screening Market by Type
7.7.2 Rest of Asia Pacific Carrier Screening Market by Technology
7.7.3 Rest of Asia Pacific Carrier Screening Market by End user

Chapter 8. Company Profiles
8.1 Quest Diagnostics, Incorporated
8.1.1 Company Overview
8.1.1 Financial Analysis
8.1.2 Recent strategies and developments:
8.1.2.1 Partnerships, Collaborations, and Agreements:
8.1.2.2 Product Launches and Product Expansions:
8.1.2.3 Acquisition and Mergers:
8.2 Thermo Fisher Scientific, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.2.5.2 Product Launches and Product Expansions:
8.2.6 SWOT Analysis
8.3 Illumina, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Acquisition and Mergers:
8.4 Eurofins Scientific Group
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Recent strategies and developments:
8.4.4.1 Partnerships, Collaborations, and Agreements:
8.4.4.2 Acquisition and Mergers:
8.5 Invitae Corporation
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent strategies and developments:
8.5.5.1 Product Launches and Product Expansions:
8.5.5.2 Acquisition and Mergers:
8.6 OPKO Health, Inc.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expenses
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.6.5.2 Acquisition and Mergers:
8.7 Fulgent Genetics
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.7.5.2 Acquisition and Mergers:
8.8 Sema4 OpCo, Inc.
8.8.1 Company Overview
8.8.2 Recent strategies and developments:
8.8.2.1 Partnerships, Collaborations, and Agreements:
8.8.2.2 Product Launches and Product Expansions:
8.9 Myriad Genetics, Inc.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental Analysis
8.9.4 Research & Development Expenses
8.9.5 Recent strategies and developments:
8.9.5.1 Partnerships, Collaborations, and Agreements:
8.9.5.2 Product Launches and Product Expansions:
8.1 Natera Inc.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional Analysis
8.10.4 Research & Development Expenses
8.10.5 Recent strategies and developments:
8.10.5.1 Partnerships, Collaborations, and Agreements:
8.10.5.2 Product Launches and Product Expansions:
TABLE 1 Asia Pacific Carrier Screening Market, 2017 - 2020, USD Million
TABLE 2 Asia Pacific Carrier Screening Market, 2021 - 2027, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Carrier Screening Market
TABLE 4 Product Launches And Product Expansions– Carrier Screening Market
TABLE 5 Acquisition and Mergers– Carrier Screening Market
TABLE 6 Asia Pacific Carrier Screening Market by Type, 2017 - 2020, USD Million
TABLE 7 Asia Pacific Carrier Screening Market by Type, 2021 - 2027, USD Million
TABLE 8 Asia Pacific Expanded Carrier Screening Market by Country, 2017 - 2020, USD Million
TABLE 9 Asia Pacific Expanded Carrier Screening Market by Country, 2021 - 2027, USD Million
TABLE 10 Asia Pacific Targeted Disease Carrier Screening Market by Country, 2017 - 2020, USD Million
TABLE 11 Asia Pacific Targeted Disease Carrier Screening Market by Country, 2021 - 2027, USD Million
TABLE 12 Asia Pacific Carrier Screening Market by Technology, 2017 - 2020, USD Million
TABLE 13 Asia Pacific Carrier Screening Market by Technology, 2021 - 2027, USD Million
TABLE 14 Asia Pacific DNA Sequencing Market by Country, 2017 - 2020, USD Million
TABLE 15 Asia Pacific DNA Sequencing Market by Country, 2021 - 2027, USD Million
TABLE 16 Asia Pacific Microarrays Market by Country, 2017 - 2020, USD Million
TABLE 17 Asia Pacific Microarrays Market by Country, 2021 - 2027, USD Million
TABLE 18 Asia Pacific Polymerase Chain Reaction Market by Country, 2017 - 2020, USD Million
TABLE 19 Asia Pacific Polymerase Chain Reaction Market by Country, 2021 - 2027, USD Million
TABLE 20 Asia Pacific Other Technologies Market by Country, 2017 - 2020, USD Million
TABLE 21 Asia Pacific Other Technologies Market by Country, 2021 - 2027, USD Million
TABLE 22 Asia Pacific Carrier Screening Market by End user, 2017 - 2020, USD Million
TABLE 23 Asia Pacific Carrier Screening Market by End user, 2021 - 2027, USD Million
TABLE 24 Asia Pacific Hospital and Clinics Market by Country, 2017 - 2020, USD Million
TABLE 25 Asia Pacific Hospital and Clinics Market by Country, 2021 - 2027, USD Million
TABLE 26 Asia Pacific Physician Offices Market by Country, 2017 - 2020, USD Million
TABLE 27 Asia Pacific Physician Offices Market by Country, 2021 - 2027, USD Million
TABLE 28 Asia Pacific Reference Laboratories Market by Country, 2017 - 2020, USD Million
TABLE 29 Asia Pacific Reference Laboratories Market by Country, 2021 - 2027, USD Million
TABLE 30 Asia Pacific Other End user Market by Country, 2017 - 2020, USD Million
TABLE 31 Asia Pacific Other End user Market by Country, 2021 - 2027, USD Million
TABLE 32 Asia Pacific Carrier Screening Market by Country, 2017 - 2020, USD Million
TABLE 33 Asia Pacific Carrier Screening Market by Country, 2021 - 2027, USD Million
TABLE 34 China Carrier Screening Market, 2017 - 2020, USD Million
TABLE 35 China Carrier Screening Market, 2021 - 2027, USD Million
TABLE 36 China Carrier Screening Market by Type, 2017 - 2020, USD Million
TABLE 37 China Carrier Screening Market by Type, 2021 - 2027, USD Million
TABLE 38 China Carrier Screening Market by Technology, 2017 - 2020, USD Million
TABLE 39 China Carrier Screening Market by Technology, 2021 - 2027, USD Million
TABLE 40 China Carrier Screening Market by End user, 2017 - 2020, USD Million
TABLE 41 China Carrier Screening Market by End user, 2021 - 2027, USD Million
TABLE 42 Japan Carrier Screening Market, 2017 - 2020, USD Million
TABLE 43 Japan Carrier Screening Market, 2021 - 2027, USD Million
TABLE 44 Japan Carrier Screening Market by Type, 2017 - 2020, USD Million
TABLE 45 Japan Carrier Screening Market by Type, 2021 - 2027, USD Million
TABLE 46 Japan Carrier Screening Market by Technology, 2017 - 2020, USD Million
TABLE 47 Japan Carrier Screening Market by Technology, 2021 - 2027, USD Million
TABLE 48 Japan Carrier Screening Market by End user, 2017 - 2020, USD Million
TABLE 49 Japan Carrier Screening Market by End user, 2021 - 2027, USD Million
TABLE 50 India Carrier Screening Market, 2017 - 2020, USD Million
TABLE 51 India Carrier Screening Market, 2021 - 2027, USD Million
TABLE 52 India Carrier Screening Market by Type, 2017 - 2020, USD Million
TABLE 53 India Carrier Screening Market by Type, 2021 - 2027, USD Million
TABLE 54 India Carrier Screening Market by Technology, 2017 - 2020, USD Million
TABLE 55 India Carrier Screening Market by Technology, 2021 - 2027, USD Million
TABLE 56 India Carrier Screening Market by End user, 2017 - 2020, USD Million
TABLE 57 India Carrier Screening Market by End user, 2021 - 2027, USD Million
TABLE 58 South Korea Carrier Screening Market, 2017 - 2020, USD Million
TABLE 59 South Korea Carrier Screening Market, 2021 - 2027, USD Million
TABLE 60 South Korea Carrier Screening Market by Type, 2017 - 2020, USD Million
TABLE 61 South Korea Carrier Screening Market by Type, 2021 - 2027, USD Million
TABLE 62 South Korea Carrier Screening Market by Technology, 2017 - 2020, USD Million
TABLE 63 South Korea Carrier Screening Market by Technology, 2021 - 2027, USD Million
TABLE 64 South Korea Carrier Screening Market by End user, 2017 - 2020, USD Million
TABLE 65 South Korea Carrier Screening Market by End user, 2021 - 2027, USD Million
TABLE 66 Singapore Carrier Screening Market, 2017 - 2020, USD Million
TABLE 67 Singapore Carrier Screening Market, 2021 - 2027, USD Million
TABLE 68 Singapore Carrier Screening Market by Type, 2017 - 2020, USD Million
TABLE 69 Singapore Carrier Screening Market by Type, 2021 - 2027, USD Million
TABLE 70 Singapore Carrier Screening Market by Technology, 2017 - 2020, USD Million
TABLE 71 Singapore Carrier Screening Market by Technology, 2021 - 2027, USD Million
TABLE 72 Singapore Carrier Screening Market by End user, 2017 - 2020, USD Million
TABLE 73 Singapore Carrier Screening Market by End user, 2021 - 2027, USD Million
TABLE 74 Malaysia Carrier Screening Market, 2017 - 2020, USD Million
TABLE 75 Malaysia Carrier Screening Market, 2021 - 2027, USD Million
TABLE 76 Malaysia Carrier Screening Market by Type, 2017 - 2020, USD Million
TABLE 77 Malaysia Carrier Screening Market by Type, 2021 - 2027, USD Million
TABLE 78 Malaysia Carrier Screening Market by Technology, 2017 - 2020, USD Million
TABLE 79 Malaysia Carrier Screening Market by Technology, 2021 - 2027, USD Million
TABLE 80 Malaysia Carrier Screening Market by End user, 2017 - 2020, USD Million
TABLE 81 Malaysia Carrier Screening Market by End user, 2021 - 2027, USD Million
TABLE 82 Rest of Asia Pacific Carrier Screening Market, 2017 - 2020, USD Million
TABLE 83 Rest of Asia Pacific Carrier Screening Market, 2021 - 2027, USD Million
TABLE 84 Rest of Asia Pacific Carrier Screening Market by Type, 2017 - 2020, USD Million
TABLE 85 Rest of Asia Pacific Carrier Screening Market by Type, 2021 - 2027, USD Million
TABLE 86 Rest of Asia Pacific Carrier Screening Market by Technology, 2017 - 2020, USD Million
TABLE 87 Rest of Asia Pacific Carrier Screening Market by Technology, 2021 - 2027, USD Million
TABLE 88 Rest of Asia Pacific Carrier Screening Market by End user, 2017 - 2020, USD Million
TABLE 89 Rest of Asia Pacific Carrier Screening Market by End user, 2021 - 2027, USD Million
TABLE 90 Key Information – Quest Diagnostics, Incorporated
TABLE 91 Key Information – Thermo Fisher Scientific, Inc.
TABLE 92 key information – Illumina, Inc.
TABLE 93 Key Information – Eurofins Scientific Group
TABLE 94 Key Information – Invitae Corporation
TABLE 95 Key Information – OPKO Health, Inc.
TABLE 96 Key Information – Fulgent Genetics
TABLE 97 Key Information – Sema4 OpCo, Inc.
TABLE 98 Key Information – Myriad Genetics, Inc.
TABLE 99 Key Information – Natera Inc.

List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2017-2021)
FIG 4 Key Strategic Move: (Product Launches and Product Expansions : 2017, Jun – 2021, Jun) Leading Players
FIG 5 Recent strategies and developments: Quest Diagnostics
FIG 6 Swot analysis: thermo fisher scientific, inc.
FIG 7 Recent strategies and developments: Sema4 OpCo, Inc.

Purchase Full Report of
Asia Pacific Carrier Screening Market

Buy Now

Avail up to 60% discount on subscription plans on

SUBSCRIPTION MODEL